116 related articles for article (PubMed ID: 6926926)
1. View from the Nation's Capitol.
Romansky MA
J Clin Psychopharmacol; 1982 Aug; 2(4):289-90. PubMed ID: 6926926
[No Abstract] [Full Text] [Related]
2. View from the Nation's Capitol.
Freishtat HW
J Clin Psychopharmacol; 1982 Apr; 2(2):146-8. PubMed ID: 6926924
[No Abstract] [Full Text] [Related]
3. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Oct; 3(5):319-21. PubMed ID: 6680407
[No Abstract] [Full Text] [Related]
4. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409
[No Abstract] [Full Text] [Related]
5. View from the Nation's Capital. NIH and ADAMHA FY 1986 appropriations.
Appler WD
J Clin Psychopharmacol; 1986 Apr; 6(2):108-9. PubMed ID: 3009560
[No Abstract] [Full Text] [Related]
6. Washington Report. Conflicting remedies for the National Institutes of Health.
Greenberg DS
N Engl J Med; 1979 May; 300(21):1231-2. PubMed ID: 431679
[No Abstract] [Full Text] [Related]
7. NIH gets a friendly hearing on Capitol Hill.
Norman C
Science; 1986 Mar; 231(4744):1364. PubMed ID: 3952487
[No Abstract] [Full Text] [Related]
8. View from the Nation's Capital. Animal research: public pressure versus research needs.
Appler WD
J Clin Psychopharmacol; 1986 Oct; 6(5):305-8. PubMed ID: 3771815
[No Abstract] [Full Text] [Related]
9. Patenting Dr. Venter's genetic findings: is the National Institutes of Health creating hurdles or clearing the path for biotechnology's voyage in the twenty-first century?
Riley PJ
J Contemp Health Law Policy; 1994; 10():309-26. PubMed ID: 10134812
[No Abstract] [Full Text] [Related]
10. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Feb; 3(1):47-8. PubMed ID: 6680403
[No Abstract] [Full Text] [Related]
11. Intellectual property issues in a clinical trial: a corporate perspective.
Fersko RS; Connolly MJ
Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679
[No Abstract] [Full Text] [Related]
12. NIH: handle with care.
Krevans JR
N Engl J Med; 1980 Jul; 303(1):45-7. PubMed ID: 7374735
[No Abstract] [Full Text] [Related]
13. "NIH-money-for-drug-patent-life" proposal rejected.
Fox JL
Nat Biotechnol; 1997 Dec; 15(13):1338. PubMed ID: 9415880
[No Abstract] [Full Text] [Related]
14. The Federal involvement in the care of patients with end-stage renal disease: the relationship to the nation's health properties.
Dirks HM
Transplant Proc; 1973 Jun; 5(2):1047-50. PubMed ID: 4579037
[No Abstract] [Full Text] [Related]
15. View from the Nation's Capitol.
Romansky MA
J Clin Psychopharmacol; 1982 Feb; 2(1):74-5. PubMed ID: 6926923
[No Abstract] [Full Text] [Related]
16. View from the nation's capital.
Romansky MA
J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923
[No Abstract] [Full Text] [Related]
17. The organizational structure of the NIH.
Stoto MA; Ebert JD
N Engl J Med; 1985 Jun; 312(25):1634-7. PubMed ID: 4000203
[No Abstract] [Full Text] [Related]
18. The Bayh-Dole Act, a lion without claws.
Feldman AM
Clin Transl Sci; 2015 Feb; 8(1):3-4. PubMed ID: 25675969
[No Abstract] [Full Text] [Related]
19. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
20. Perspectives. Medical research: coping in a new era.
Sorian R
Faulkner Grays Med Health; 1991 Mar; 45(10):suppl 4 p.. PubMed ID: 10109290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
